ILMN
57
-3
PH
60
-7
MCK
52
-3
EQIX
64
-3
PNW
70
4
COST
57
6
VRSK
56
-3
BAC
50
5
LH
42
7
TXT
63
-6
UNP
49
3
BMY
40
5
LLY
56
2
FAST
60
-4
DGX
43
11
MPC
62
32
ORLY
64
-2
SHW
52
-9
CNP
60
-5
REGN
48
4
ILMN
57
-3
PH
60
-7
MCK
52
-3
EQIX
64
-3
PNW
70
4
COST
57
6
VRSK
56
-3
BAC
50
5
LH
42
7
TXT
63
-6
UNP
49
3
BMY
40
5
LLY
56
2
FAST
60
-4
DGX
43
11
MPC
62
32
ORLY
64
-2
SHW
52
-9
CNP
60
-5
REGN
48
4
Financhill
Back

Ultragenyx Pharmaceutical Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
47

RARE
Ultragenyx Pharmaceutical

Last Price:
54.85
Seasonality Move:
12.42%
Sell
28

NBY
NovaBay Pharmaceuticals

Last Price:
0.56
Seasonality Move:
-16.74%
Sell
47
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $54.79. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.59. The Score for NBY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $54.79
    The current trend is moderately bearish and RARE is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 47.17 Sell
Chaikin Money Flow: 157903 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.97 - 57.61) Sell
Bollinger Bands (100): (42.49 - 56.25) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 42.74 Sell
Chaikin Money Flow: 36308 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.58 - 0.72) Sell
Bollinger Bands (100): (0.35 - 2.23) Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.68 Sell
20-day SMA: 55.18 Sell
50-day SMA: 55.69 Sell
200-day SMA: 47.54 Buy
8-day EMA: 55.4 Sell
20-day EMA: 55.43 Sell
50-day EMA: 54.18 Buy
200-day EMA: 48.46 Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.61 Sell
20-day SMA: 0.66 Sell
50-day SMA: 0.57 Buy
200-day SMA: 2.9 Sell
8-day EMA: 0.62 Sell
20-day EMA: 0.63 Sell
50-day EMA: 0.78 Sell
200-day EMA: 6.83 Sell

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $1.10 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):